Oncopeptides AB 2020 Investor Call - Transformation

Oncopeptides AB investor call presentation from November 2020, addressing the company's transformation strategy. Led by Chief Executive Officer Marty J. Duvall, the presentation covers oncology-focused pharmaceutical development and commercial initiatives.